Baricitinib 4 mg (Generic)
| Active Ingredient | Baricitinib |
|---|---|
| Indication: | Rheumatoid arthritis |
| Manufacturer: | Eli Lilly and Company India |
| Packaging | 7 tablets in 1 strip |
| Strength | 4mg |
| Delivery Time | 6 To 15 days |
Baricitinib 4 mg (Generic) is an oral JAK inhibitor used for the treatment of moderate to severe rheumatoid arthritis, especially in patients who have not responded well to other DMARDs (disease-modifying antirheumatic drugs). It helps relieve joint pain, swelling, and improves physical function in chronic inflammatory conditions.
Baricitinib works by selectively blocking Janus kinase enzymes, which play a key role in the body’s immune response. By reducing immune system overactivity, it helps to slow joint damage and decrease inflammation. It is also sometimes used under medical supervision for treating COVID-19-related complications and alopecia areata.
Patients should take Baricitinib 4 mg exactly as prescribed by their doctor. Regular blood tests may be required to monitor immune function. This targeted immune therapy is a breakthrough option for those needing long-term management of autoimmune disorders.








There are no reviews yet.